Westminster-based ARCA Biopharma Inc. (NASDAQ: ABIO) announced the completion of its merger with Oruka Therapeutics Inc. The merger follows ARCA’s successful receipt of stockholder approval for all related proposals at a special meeting on Aug. 22, 2024. The combined company will operate as “Oruka Therapeutics Inc.”, with its common stock to be traded on Nasdaq…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here